Characterizing patients prescribed resmetirom for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in a real-world setting: A United States cohort study using electronic medical records

Poster Presentation

File size: 568.62 KB
Created: 06-05-2025
Updated: 06-05-2025
Hits: 6
Download Preview

© Madrigal Pharmaceuticals, Inc. All rights reserved.
MED-AT-MGL-3196-2300027

Go to Top